用弗卢马泽尼尔逆转二甲胺耐受性的可行性
I Savic1, L Widén, S Stone-Elander
1Department of Clinical Neurophysiology, Karolinska Hospital, Stockholm, Sweden.
Lancet (London, England)
|January 19, 1991
概括
弗卢马泽尼尔是一种二胺抗剂,可以在患者中逆转对二胺的耐受性,而不会引起戒断发作. 建议对间歇性治疗潜力进行进一步的研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 类药物通常用于,但可能导致耐受性.
- 诸如弗卢马泽尼尔之类的二胺抗剂可能提供一种管理这种耐受性的方法.
研究的目的:
- 调查弗卢马泽尼尔是否可以在不诱发戒断发作的情况下逆转二甲耐受性.
- 为了评估flumazenil的抗作用和受体占用率.
- 为了确定最佳的剂量来逆转耐受性.
主要方法:
- 电脑电图 (EEG) 研究12名患有部分和泛发作的患者.
- 用静脉注射弗卢马塞尼尔 (1.5 mg 和 15 mg) 的不同剂量进行受体占用研究.
- 给1.5毫克弗鲁马泽尼尔给3名耐受克洛纳泽帕姆的患者.
主要成果:
- 弗卢马泽尼尔在部分发作中对性排泄产生了短暂的,非剂量依赖的抑制作用.
- 1.5毫克弗鲁马塞尼尔占据了55%的受体,15毫克占据了几乎所有的受体.
- 三名耐受克洛纳泽帕姆的患者在1.5毫克弗鲁马泽尼尔后6-21天没有发作.
结论:
- 弗卢马泽尼尔显示出在中逆转二胺耐受性的潜力.
- 间歇性使用二胺抗剂的治疗需要进一步的研究,以控制二胺耐受性.
- 弗卢马泽尼尔可能为患有症患者提供治疗策略,这些患者经历了二胺耐受性.
更多相关视频
相关概念视频
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...


